Thus, the capacity of PRL/STAT5 signaling to induce the amplification of stem/progenitor cells may directly contribute to cancer progression by feeding the prostate tissue with cells able to resist treatments and to regrow a tumor (cancer recurrence). The gene discussed is STAT5B; the disease is neoplasm.